| 08/07/2026 4:28 PM | MORGAN STANLEY (895421) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 08/07/2026 4:32 PM | MORGAN STANLEY (895421) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 08/07/2026 10:07 AM | FMR LLC (315066) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 08/06/2026 9:48 AM | FMR LLC (315066) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 07/31/2026 9:47 AM | VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 07/30/2026 10:18 AM | BlackRock, Inc. (2012383) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 07/20/2026 3:40 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:22 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:25 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:26 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:28 PM | XOMA (791908) Filer | Form S-8 POS | |
Get the Latest News and Ratings for XOMAP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/20/2026 3:29 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:29 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:30 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:31 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:34 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:35 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:35 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:36 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:16 PM | XOMA (791908) Filer | Form POS AM | |
| 07/20/2026 3:19 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/16/2026 4:00 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA (791908) Subject | Form SCHEDULE 13D/A | |
| 07/16/2026 4:02 PM | BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting BIOTECHNOLOGY VALUE FUND L P (918923) Reporting Biotechnology Value Trading Fund OS LP (1660683) Reporting BVF GP HOLDINGS LLC (1803809) Reporting BVF I GP LLC (1803805) Reporting BVF II GP LLC (1803806) Reporting BVF INC/IL (1056807) Reporting BVF PARTNERS L P/IL (1055947) Reporting BVF Partners OS Ltd. (1660684) Reporting LAMPERT MARK N (1233840) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2026 7:31 AM | Nasdaq Stock Market LLC (1354457) Filed by XOMA (791908) Subject | Form 25-NSE | |
| 07/15/2026 9:39 AM | Nasdaq Stock Market LLC (1354457) Filed by XOMA (791908) Subject | Form 25-NSE | |
| 07/14/2026 8:45 PM | Franklin Heather L (1436658) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | PERRY MATTHEW D (1454337) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Hernday Natasha (1780547) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Kosacz Barbara (1763316) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | LIMBER JOSEPH M (1216023) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:10 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 4:22 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 4:24 PM | XOMA (791908) Filer | Form DEFA14A | |
| 06/10/2026 4:19 PM | XOMA (791908) Filer | Form DEFM14A | |
| 05/26/2026 5:07 PM | Kosacz Barbara (1763316) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:07 PM | Franklin Heather L (1436658) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (Ad) In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon adviser Jim Rickards publicly predicted a Trump victory before election night.
Now Rickards is issuing a new forecast he calls a potential mid-term meltdown, one he believes could send shockwaves through financial markets. See Jim Rickards' full market warning and what it means for your portfolio |
| 05/26/2026 5:08 PM | PERRY MATTHEW D (1454337) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | Hernday Natasha (1780547) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | LIMBER JOSEPH M (1216023) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 10:28 AM | XOMA (791908) Subject | Form 425 | |
| 05/22/2026 5:01 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 4:26 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA (791908) Subject | Form SCHEDULE 13D/A | |
| 05/18/2026 4:29 PM | BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting BIOTECHNOLOGY VALUE FUND L P (918923) Reporting Biotechnology Value Trading Fund OS LP (1660683) Reporting BVF GP HOLDINGS LLC (1803809) Reporting BVF I GP LLC (1803805) Reporting BVF II GP LLC (1803806) Reporting BVF INC/IL (1056807) Reporting BVF PARTNERS L P/IL (1055947) Reporting BVF Partners OS Ltd. (1660684) Reporting LAMPERT MARK N (1233840) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 8:11 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 8:13 AM | XOMA (791908) Filer | Form DEFA14A | |
| 05/15/2026 8:03 AM | Woodline Partners LP (1784547) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 05/12/2026 3:06 PM | XOMA (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 8:15 PM | LIGAND PHARMACEUTICALS INC (886163) Filed by XOMA (791908) Subject | Form SCHEDULE 13D | |
| 04/30/2026 1:38 PM | VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 04/29/2026 4:43 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA (791908) Subject | Form SCHEDULE 13D/A | |
| 04/27/2026 6:37 PM | LIGAND PHARMACEUTICALS INC (886163) Filer XOMA (791908) Filer | Form DEFA14A | |
| 04/27/2026 3:12 PM | BlackRock, Inc. (2012383) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 04/27/2026 3:01 PM | XOMA (791908) Filer | Form 8-K/A | |
| 04/27/2026 7:16 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/27/2026 7:19 AM | XOMA (791908) Filer | Form DEFA14A | |
| 04/22/2026 3:30 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:13 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:30 PM | LIMBER JOSEPH M (1216023) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 4:34 PM | XOMA (791908) Filer | Form DEFA14A | |
| 03/30/2026 4:35 PM | XOMA (791908) Filer | Form ARS | |
| 03/27/2026 1:14 PM | VANGUARD GROUP INC (102909) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 03/26/2026 3:30 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 5:45 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 3:38 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 9:05 AM | FMR LLC (315066) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 03/02/2026 5:04 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 1:36 PM | MORGAN STANLEY (895421) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 3:19 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/30/2026 4:14 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 01/15/2026 3:25 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 01/14/2026 3:35 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 6:58 AM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 01/12/2026 6:00 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:05 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T | |
| 12/15/2025 7:36 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-C | |
| 12/05/2025 8:15 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/21/2025 6:50 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 11/21/2025 7:03 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Central banks bought 710 tonnes - this fund pays monthly (Ad) Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan is now targeting $4,900.
One $15 fund is converting gold's momentum into up to $1,152 per month in payouts. No miners, no active trading - just monthly income. See how to collect your first payout before the next surge |
| 11/13/2025 6:16 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 11/12/2025 6:46 AM | XOMA (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2025 6:46 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 11:22 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 10/03/2025 4:24 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/03/2025 4:00 PM | XOMA (791908) Filer | Form 424B5 | |
| 10/03/2025 4:03 PM | XOMA (791908) Filer | Form 424B5 | |
| 10/02/2025 3:35 PM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 09/26/2025 4:29 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |